Background illustration for clinical trials search

Paid Clinical Trials New Jersey

Discover 1,658 paid clinical trials in New Jersey. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

for
Intracerebral Hemorrhage, Atrial Fibrillation
Location: Portland ME, Boston MA, Burlington MA, Worcester MA,
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT03907046

Phase3, Recruiting

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

for
Childhood Extracranial Germ Cell Tumor,
Location: St. John's, Halifax, Bangor ME, Portland ME,
Sponsor: Children's Oncology Group

Sex: All

Age: 0+

Code: NCT03067181

Phase3, Recruiting

A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Boston MA, New York NY, Hackensack NJ,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06973187

Phase3, Recruiting

A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

for
Central Nervous System Nongerminomatous Germ Cell Tumor,
Location: Halifax, Bangor ME, Scarborough ME, Boston MA,
Sponsor: Children's Oncology Group

Sex: All

Age: 3 - 29

Code: NCT04684368

Phase2, Recruiting

Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery

for
Grade 2 Meningioma, Intracranial Meningioma
Location: Bath ME, Portland ME, Scarborough ME, Sanford ME,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT03180268

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

for
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Location: Halifax, Bangor ME, Bath ME, Portland ME,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 5 - 60

Code: NCT05675410

Phase3, Recruiting

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

for
Breast Cancer, Metastatic Breast Cancer, Breast Neoplasm,
Location: Riverhead NY, Patchogue NY, Port Jefferson Station NY,
Sponsor: BriaCell Therapeutics Corporation

Sex: All

Age: 18+

Code: NCT06072612

Phase3, Recruiting

Online Rotating Delivery of Perception/Production Enhanced Treatment for Rhotics

for
Speech Sound Disorder
Location: Montclair NJ
Sponsor: Montclair State University

Sex: All

Age: 8 - 17

Code: NCT06969521

Recruiting

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

for
Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis
Location: Boston MA, Providence RI, Burlington MA, New Haven CT,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06119581

Phase3, Recruiting

Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects

for
Malignancy
Location: Brewer ME, Boston MA, Providence RI, West Haven CT,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 0+

Code: NCT04242095

Recruiting

A Study of T3011 in Patients With BCG-Unresponsive NMIBC or BCG-Exposed, Chemotherapy-Unresponsive NMIBC

for
Nonmuscle-invasive Bladder Cancer
Location: New Brunswick NJ, Myrtle Beach SC, Pittsburgh PA,
Sponsor: ImmVira Pharma Co. Ltd

Sex: All

Age: 18+

Code: NCT06971614

Phase2, Recruiting

A Study of Hospital-at-Home for People Receiving Tarlatamab

for
Small-cell Lung Cancer, Small Cell Lung Carcinoma
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT06957314

Recruiting

A Study of ASTX727 in People With Malignant Peripheral Nerve Sheath Tumors (MPNST)

for
Malignant Peripheral Nerve Sheath Tumors (MPNST)
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 16+

Code: NCT04872543

Phase2, Recruiting

Collecting Information About Treatment Results for Patients With Cushing's Syndrome

for
Cushing's Disease, Cushing Syndrome, Cushing Disease
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 14+

Code: NCT03364803

Recruiting

International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry

for
Gaucher Disease, Cerebroside Lipidosis Syndrome,
Location: Moncton, Portland ME, Boston MA, New Haven CT,
Sponsor: Genzyme, a Sanofi Company

Sex: All

Age: 0+

Code: NCT00358943

Recruiting

Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain

for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Portland ME, Scarborough ME, Sanford ME, Stony Brook NY,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT06500455

Phase3, Recruiting

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

for
Castration Levels of Testosterone,
Location: Brewer ME, Bath ME, Portland ME, Scarborough ME,
Sponsor: SWOG Cancer Research Network

Sex: Male

Age: 18+

Code: NCT03678025

Phase3, Recruiting

Amnioband and Standard of Care vs. Standard of Care Alone in the Treatment of Venous Leg Ulcers

for
Venous Leg Ulcers
Location: Boston MA, Brick NJ, Martinsville VA, Ford City PA,
Sponsor: SerenaGroup, Inc.

Sex: All

Age: 18+

Code: NCT02609594

Recruiting

A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement

for
Breast Cancer
Location: Commack NY, Rockville Centre NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: Female

Age: 18+

Code: NCT07220967

Recruiting

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

for
Neoplasms
Location: Boston MA, New Haven CT, New York NY, Hackensack NJ,
Sponsor: Celgene

Sex: All

Age: 0+

Code: NCT03435796

Phase2, Phase3, Recruiting

Popular cities in New Jersey

New Jersey is a vital center for a diverse array of clinical trials, largely in part due to its robust healthcare network and prominent medical research institutions. Key organizations such as Rutgers Cancer Institute, Hackensack Meridian Health, and Cooper University Health Care are leading the way in groundbreaking studies in the state. These institutions are recognized for their innovative research in areas like cancer, cardiovascular health, and neurology, making New Jersey a critical player in advancing medical science and patient care.

Why choose New Jersey for clinical trials?

New Jersey offers a vast array of advantages for individuals considering participation in clinical trials. The state has a diverse population, which enriches the participant pool and improves the reliability and applicability of research findings. Additionally, New Jersey is home to some of the nation’s leading medical research institutions, known for their innovative approaches and focus on advancing healthcare.

By choosing to participate in a clinical trial in New Jersey, participants not only gain access to cutting-edge treatments but also play a vital role in advancing important medical research. The state’s well-established clinical research infrastructure ensures participants receive exceptional care and support throughout their journey, contributing to meaningful advancements in healthcare.

Common conditions studied in New Jersey

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in New Jersey